Sign inGet started

Bair Teresa Brophy

Insider CIK 1813058 · ATNX General Counsel, SVP Admin. · KURA Chief Legal Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
KURA Kura Oncology, Inc. S Sale2026-09-282026-09-298,442$10.50 $88.6K187,002SEC↗
KURA Kura Oncology, Inc. S Sale2026-09-282026-09-298,442$10.50 $88.6K187,002SEC↗
KURA Kura Oncology, Inc. S Sale2026-08-192026-08-2131,487$12.63 $397.7K195,444SEC↗
KURA Kura Oncology, Inc. S Sale2026-08-192026-08-2131,487$12.63 $397.7K195,444SEC↗
KURA Kura Oncology, Inc. S Sale2026-05-182026-05-202,256$9.38 $21.2K226,931SEC↗
KURA Kura Oncology, Inc. S Sale2026-01-272026-01-274,096$8.46 $34.7K234,043SEC↗
KURA Kura Oncology, Inc. S Sale2026-01-272026-01-272,335$8.46 $19.8K231,708SEC↗
KURA Kura Oncology, Inc. S Sale2026-01-272026-01-274,777$8.46 $40.4K226,931SEC↗
KURA Kura Oncology, Inc. A Award deriv2026-01-022026-01-06100,000— $0100,000SEC↗
KURA Kura Oncology, Inc. A Award2026-01-022026-01-0650,000— $0238,139SEC↗
KURA Kura Oncology, Inc. S Sale2025-11-142025-11-148,804$11.18 $98.4K188,139SEC↗
KURA Kura Oncology, Inc. A Award2025-11-132025-11-1448,900— $0196,943SEC↗
KURA Kura Oncology, Inc. S Sale2025-09-292025-09-298,805$8.94 $78.7K148,043SEC↗
KURA Kura Oncology, Inc. A Award2025-09-272025-09-2948,900— $0156,848SEC↗
KURA Kura Oncology, Inc. S Sale2025-05-192025-05-191,559$5.96 $9.3K107,948SEC↗
KURA Kura Oncology, Inc. S Sale2025-01-282025-01-282,437$7.87 $19.2K112,792SEC↗
KURA Kura Oncology, Inc. S Sale2025-01-282025-01-284,844$7.87 $38.1K107,948SEC↗
KURA Kura Oncology, Inc. A Award deriv2025-01-022025-01-0692,500— $092,500SEC↗
KURA Kura Oncology, Inc. A Award2025-01-022025-01-0646,250— $0115,229SEC↗
KURA Kura Oncology, Inc. S Sale2024-05-202024-05-202,615$22.15 $57.9K68,979SEC↗
KURA Kura Oncology, Inc. S Sale2024-01-292024-01-312,053$17.80 $36.5K68,979SEC↗
KURA Kura Oncology, Inc. A Award deriv2024-01-022024-01-0492,500— $092,500SEC↗
KURA Kura Oncology, Inc. A Award2024-01-022024-01-0446,250— $071,032SEC↗
KURA Kura Oncology, Inc. A Award deriv2023-02-162023-02-21138,750— $0138,750SEC↗
KURA Kura Oncology, Inc. A Award2023-02-162023-02-2123,125— $023,125SEC↗
KURA Kura Oncology, Inc. S Sale2022-11-172022-11-182,100$15.22 $32.0K0SEC↗
KURA Kura Oncology, Inc. A Award deriv2021-10-182021-10-19192,000— $0192,000SEC↗
ATNX Athenex, Inc. A Award deriv2021-08-032021-08-0537,500— $037,500SEC↗
ATNX Athenex, Inc. A Award deriv2021-08-032021-08-0537,500— $037,500SEC↗
ATNX Athenex, Inc. A Award deriv2020-08-272020-08-3115,000— $015,000SEC↗
ATNX Athenex, Inc. A Award deriv2020-08-052020-08-0760,000— $060,000SEC↗